Apple joins the Global fight against HIV/AIDS with the Release of iPhone (Red)
Apple shakes hands with (RED) Charity in a bid to wipe off HIV/AIDS. As the company launces iPhone7 and iPhone7plus, the tech giant will make a donation from a portion of each device sold to help fund the charity work in the sub-Saharan Africa.
In a press release, Deborah Dugan, (RED)’s CEO, said “Combining the global reach of the world’s most loved smartphone with our efforts to provide access to life-saving ARV medication in sub-Saharan Africa, customers now have a remarkable opportunity to make a difference and contribute to the Global Fund through the purchase of this new beautiful (PRODUCT)RED iPhone.”
Apple believes that this will give customers an unprecedented way to contribute to the Global Fund and bring the world a step closer to an AIDS-free generation.
The new red aluminium iPhone will be available in 128GB and 256GB capacities and will be available starting March 24 in select countries. The Red Special edition of the iPhone will be priced in India starting Rs 82,000 and upwards and will be available in April.
(RED) supports The Global Fund HIV/AIDS grants in eight countries with a goal of virtually eliminating transmission of the virus from moms to their babies.
An HIV-positive mother can pass HIV on to her baby any time during pregnancy, labor, delivery and breastfeeding, so the transmission of the virus must be blocked at each stage. Current World Health Organization guidelines recommend that HIV-positive pregnant mothers should go on a triple-drug regimen of antiretroviral medication (ARVs) through pregnancy, delivery and breastfeeding. Ideally, the mothers themselves will also remain on treatment once breastfeeding has concluded, for their own health.
ARVs work to keep HIV from growing and multiplying within the human body. With access to ARVs, people living with HIV can not only lead healthy and productive lives, but they can pass on healthy lives to their unborn children.
As soon as the infant is born, the baby should be given nevirapine daily for six weeks. Based on her individual circumstance, the mother should receive counseling and guidance from her healthcare provider on whether the infant should be formula-fed or breastfed.
If the mother is to breastfeed, it is recommended that she do so exclusively for six months while continuing to take her ARVs. After six months, the mother can introduce appropriate complementary foods, and continue breastfeeding for the first 12 months of the child’s life.
Mothers who adhere to this regimen can reduce the risk of transmission of HIV to their babies to less than 5%. These prevention guidelines have evolved over the years as scientists have learned more about how to most effectively reduce the risk of transmission while also working to minimize drug resistance for our most effective treatment tools.